FDA's Medical Device Remarketer Decision Expected By End Of 1998
This article was originally published in The Gray Sheet
FDA expects to decide by year-end how it will regulate refurbishers, rebuilders, reconditioners, independent servicers and "as is" remarketers of medical equipment, according to Center for Device and Radiological Health Office of Compliance Deputy Director Phil Frappaolo.
You may also be interested in...
The series D financing will support the expansion of Everlywell’s consumer lab testing and digital health businesses.
New guidance from the UK regulator covers distribution and deployment of Pfizer/BioNTech's COVID-19 vaccine, which will be complex because of the temperature storage requirements and the large packs in which the vaccine doses will be delivered.
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.